PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
PURPLE BIOTECH LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$1.08−0.06 (-5.26%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 40.0
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 1.86B shares
Institutional holders
13
5 new, 7 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 605,000 | 9.90% | 13G (passive) | Sep 4, 2025 |
| Orca Capital AG | 605,000 | 9.90% | 13G (passive) | Sep 4, 2025 |
| Mitchell P. Kopin | 282,513,535 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Steven Boyd | 223,000 | 8.69% | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PPBT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| SmartHarvest Portfolios, LLC | 28,468 | 0.00% | $47.83K | +10,341 | 0.02% |
| Hrt Financial LP | 14,640 | 0.00% | $24 | New | 0.00% |
| Citadel Advisors LLC | 13,166 | 0.00% | $22.12K | New | 0.00% |
| Susquehanna International Group, Llp | 12,847 | 0.00% | $21.58K | −40,556 | 0.00% |
| Independent Advisor Alliance | 11,901 | 0.00% | $19.99K | New | 0.00% |
| SRS Capital Advisors, Inc. | 1,453 | 0.00% | $2.44K | New | 0.00% |
| Rhumbline Advisers | 856 | 0.00% | $1.44K | +146 | 0.00% |
| UBS Group AG | 751 | 0.00% | $1.26K | +652 | 0.00% |
| Morgan Stanley | 197 | 0.00% | $331 | −381 | 0.00% |
| Royal Bank of Canada | 128 | 0.00% | $0 | +118 | 0.00% |
| Northwestern Mutual Wealth Management Co | 8 | 0.00% | $13 | – | 0.00% |
| IFG Advisory, LLC | 7 | 0.00% | $12 | New | 0.00% |
| SBI Securities Co., Ltd. | 3 | 0.00% | $5 | −28 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 13 | 0M | 0.0% | 5 / 4 | 3 / 7 | 0M | 0M |
| Q1 2026 | 15 | 0M | 0.0% | 15 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PPBT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | 10 | 0.00% | $17 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gil Efron | Chief Executive Officer | 15,750,000 | 0.85% | Mar 31, 2026 |
| Shai S. Lankry | Chief Financial Officer | 3,550,000 | 0.19% | Mar 30, 2026 |
| Michael Schickler | Head of Clinical & Reg Affairs | 9,254,472 | 0.50% | Mar 30, 2026 |
| Simcha Rock | Director | 3,207,690 | 0.17% | Apr 17, 2026 |
| Suzana Zilberberg | Director | 3,062,500 | 0.16% | Apr 7, 2026 |
| Ido Agmon | Director | 3,093,860 | 0.17% | Apr 6, 2026 |
| Robert E. Gagnon | Director | 3,062,500 | 0.16% | Mar 18, 2026 |